Filing Flows › Gilead Sciences (GILD) › Guidance history
Gilead Sciences (GILD) guidance history: what it guided and what it reported
Gilead Sciences gave guidance in 12 earnings releases on file since Feb 6, 2024. Of 2 guided periods since reported, it met or beat its own guidance once (50%). GAAP tax rate: 1 of 2, on average +1.4 pts against the guided midpoint. Its releases raised guidance 5 times and lowered it 9 times.
GAAP gross margin
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 79.0% (Feb 10, 2026) → reaffirmed 79.0% (May 7, 2026) → reaffirmed 79.0% (Aug 4, 2026) → reaffirmed 79.0% (Oct 29, 2026) | — | to be reported | — |
| FY2025 | 77.0%–78.0% (Feb 11, 2025) → reaffirmed 77.0%–78.0% (Apr 24, 2025) → reaffirmed 77.0%–78.0% (Aug 7, 2025) → reaffirmed 77.0%–78.0% (Oct 30, 2025) | — | — | — |
| FY2024 | 76.0%–77.0% (Feb 6, 2024) → reaffirmed 76.0%–77.0% (Apr 25, 2024) → reaffirmed 76.0%–77.0% (Aug 8, 2024) → reaffirmed 76.0%–77.0% (Nov 6, 2024) | — | — | — |
Adjusted gross margin
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 87.0% (Feb 10, 2026) → reaffirmed 87.0% (May 7, 2026) → reaffirmed 87.0% (Aug 4, 2026) → reaffirmed 87.0% (Oct 29, 2026) | — | to be reported | — |
| FY2025 | 85.0%–86.0% (Feb 11, 2025) → reaffirmed 85.0%–86.0% (Apr 24, 2025) → reaffirmed 85.0%–86.0% (Aug 7, 2025) → reaffirmed 85.0%–86.0% (Oct 30, 2025) | — | — | — |
| FY2024 | 85.0%–86.0% (Feb 6, 2024) → reaffirmed 85.0%–86.0% (Apr 25, 2024) → reaffirmed 85.0%–86.0% (Aug 8, 2024) → reaffirmed 85.0%–86.0% (Nov 6, 2024) | — | — | — |
GAAP tax rate
Met or beat 1 of 2 periods (1 above, 0 within, 1 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 21.0% (Feb 10, 2026) → reaffirmed 21.0% (May 7, 2026) → reaffirmed 21.0% (Aug 4, 2026) → reaffirmed 21.0% (Oct 29, 2026) | — | to be reported | — |
| FY2025 | 20.0% (Feb 11, 2025) → reaffirmed 20.0% (Apr 24, 2025) → reaffirmed 20.0% (Aug 7, 2025) | 13.1% | below the range | -6.9 pts |
| FY2024 | 21.0% (Feb 6, 2024) → reaffirmed 21.0% (Apr 25, 2024) → reaffirmed 21.0% (Aug 8, 2024) → reaffirmed 21.0% (Nov 6, 2024) | 30.6% | above the range | +9.6 pts |
Adjusted tax rate
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 20.0% (Feb 10, 2026) → reaffirmed 20.0% (May 7, 2026) → reaffirmed 20.0% (Aug 4, 2026) → reaffirmed 20.0% (Oct 29, 2026) | — | to be reported | — |
| FY2025 | 19.0% (Feb 11, 2025) → reaffirmed 19.0% (Apr 24, 2025) → reaffirmed 19.0% (Aug 7, 2025) → reaffirmed 19.0% (Oct 30, 2025) | — | — | — |
| FY2024 | 19.0% (Feb 6, 2024) → reaffirmed 19.0% (Apr 25, 2024) → reaffirmed 19.0% (Aug 8, 2024) → reaffirmed 19.0% (Nov 6, 2024) | — | — | — |
GAAP EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $6.75–$7.15 (Feb 10, 2026) → reaffirmed $6.75–$7.15 (May 7, 2026) → raised $9.08 (Aug 4, 2026) → raised $9.88 (Oct 29, 2026) | — | to be reported | — |
| FY2025 | $5.95–$6.35 (Feb 11, 2025) → reaffirmed $5.95–$6.35 (Apr 24, 2025) → reaffirmed $5.95–$6.35 (Aug 7, 2025) → reaffirmed $5.95–$6.35 (Oct 30, 2025) | — | — | — |
| FY2024 | $5.15–$5.55 (Feb 6, 2024) → reaffirmed $5.15–$5.55 (Apr 25, 2024) → reaffirmed $5.15–$5.55 (Aug 8, 2024) → reaffirmed $5.15–$5.55 (Nov 6, 2024) | — | — | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $8.45–$8.85 (Feb 10, 2026) → reaffirmed $8.45–$8.85 (May 7, 2026) → raised $9.08 (Aug 4, 2026) → raised $9.88 (Oct 29, 2026) | — | to be reported | — |
| FY2025 | $7.70–$8.10 (Feb 11, 2025) → reaffirmed $7.70–$8.10 (Apr 24, 2025) → reaffirmed $7.70–$8.10 (Aug 7, 2025) → reaffirmed $7.70–$8.10 (Oct 30, 2025) | — | — | — |
| FY2024 | $6.85–$7.25 (Feb 6, 2024) → reaffirmed $6.85–$7.25 (Apr 25, 2024) → reaffirmed $6.85–$7.25 (Aug 8, 2024) → reaffirmed $6.85–$7.25 (Nov 6, 2024) | — | — | — |
The latest quarter
Gilead Sciences, Q3 2026: revenue $8.3B (+7% year over year), operating margin 41.7%, net earnings $2.4B, operating cash flow $5.0B. The chart follows the revenue to costs, profit and cash.
Questions
Does Gilead Sciences beat its guidance?
Gilead Sciences gave guidance in 12 earnings releases on file since Feb 6, 2024. Of 2 guided periods since reported, it met or beat its own guidance once (50%). GAAP tax rate: 1 of 2, on average +1.4 pts against the guided midpoint.
How often does Gilead Sciences raise guidance?
Its earnings releases raised guidance 5 times and lowered it 9 times since Feb 6, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.